AU2001295194A1 - Methods and compositions for producing donor cells - Google Patents

Methods and compositions for producing donor cells

Info

Publication number
AU2001295194A1
AU2001295194A1 AU2001295194A AU9519401A AU2001295194A1 AU 2001295194 A1 AU2001295194 A1 AU 2001295194A1 AU 2001295194 A AU2001295194 A AU 2001295194A AU 9519401 A AU9519401 A AU 9519401A AU 2001295194 A1 AU2001295194 A1 AU 2001295194A1
Authority
AU
Australia
Prior art keywords
compositions
methods
donor cells
producing donor
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295194A
Inventor
Hal Sternberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biotime Inc
Original Assignee
Biotime Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biotime Inc filed Critical Biotime Inc
Publication of AU2001295194A1 publication Critical patent/AU2001295194A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8773—Ovine embryos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2517/00—Cells related to new breeds of animals
    • C12N2517/04—Cells produced using nuclear transfer
AU2001295194A 2000-05-04 2001-04-27 Methods and compositions for producing donor cells Abandoned AU2001295194A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20237700P 2000-05-04 2000-05-04
US60/202377 2000-05-04
PCT/US2001/013669 WO2001083731A1 (en) 2000-05-04 2001-04-27 Methods and compositions for producing donor cells

Publications (1)

Publication Number Publication Date
AU2001295194A1 true AU2001295194A1 (en) 2001-11-12

Family

ID=22749619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295194A Abandoned AU2001295194A1 (en) 2000-05-04 2001-04-27 Methods and compositions for producing donor cells

Country Status (3)

Country Link
US (1) US20030115623A1 (en)
AU (1) AU2001295194A1 (en)
WO (1) WO2001083731A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060147429A1 (en) * 2004-12-30 2006-07-06 Paul Diamond Facilitated cellular reconstitution of organs and tissues

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204053B1 (en) * 1994-11-08 2001-03-20 Diacrin, Inc. Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases
US5945577A (en) * 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells

Also Published As

Publication number Publication date
WO2001083731A1 (en) 2001-11-08
US20030115623A1 (en) 2003-06-19

Similar Documents

Publication Publication Date Title
AU2001294198A1 (en) Cells producing antibody compositions
AU2001252014A1 (en) Photovoltaic cell
AU2002213273A1 (en) Stenoprophiluric matrices, and methods of making and using the same
AUPQ419099A0 (en) Novel compositions and methods
AU2001245337A1 (en) Electrical cells, components and methods
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU782917C (en) Cell division inhibitors and process for producing the same
AU2001229731A1 (en) Human embryoid body-derived cells
EP1130098A3 (en) Mammalian osteoregulins
AU2001260847A1 (en) Compositions isolated from skin cells and methods for their use
AU2001219651A1 (en) Mulch composition and method
AU2001250036A1 (en) Microdroplet cell culture technique
AU2001292317A1 (en) Fuel cell
AU2001251137A1 (en) Methods and products for regulating cell motility
AU2001252015A1 (en) Photovoltaic cell
AU2002231295A1 (en) Developed seed and methods for making the same
AU2001290319A1 (en) Fuel cell and method for preparation thereof
AU2001293074A1 (en) Human liver cell line
AU2001233932A1 (en) Method and composition
AU2002216223A1 (en) Preservation of cells
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001294010A1 (en) Stem cells
AU2001236755A1 (en) Structures and methods for improved capacitor cells
AU2001266176A1 (en) Methods
AU4771600A (en) Cells, culture methods and their uses